Volume 10,Issue 7
Objective: To investigate the clinical efficacy of traditional Chinese medicine (TCM) syndrome differentiation in the treatment of patients with gouty nephropathy. Methods: From June 2023 to December 2024, 80 patients with gouty nephropathy were selected as samples and randomly divided into two groups: group A received TCM syndrome differentiation treatment, while group B received conventional treatment. The efficacy, laboratory indicators, symptom scores, and safety were compared between the two groups. Results: The efficacy of group A was higher than that of group B (P < 0.05). The uric acid, blood urea nitrogen, serum creatinine, and 24-hour urinary protein levels in group A were lower than those in group B (P < 0.05). The symptom score of group A was lower than that of group B (P < 0.05). The adverse reactions of gouty nephropathy in group A were lower than those in group B (P < 0.05). Conclusion: TCM syndrome differentiation treatment for gouty nephropathy can alleviate symptoms, protect renal function, and is highly effective and feasible